Last reviewed · How we verify
SVT-15652
SVT-15652 is a small molecule that targets the cardiac sodium channel.
SVT-15652 is a small molecule that targets the cardiac sodium channel. Used for Atrial fibrillation for stroke prevention.
At a glance
| Generic name | SVT-15652 |
|---|---|
| Also known as | SVT-15652 Otic Solution |
| Sponsor | Salvat |
| Drug class | sodium channel blocker |
| Target | cardiac sodium channel |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
By inhibiting the cardiac sodium channel, SVT-15652 is expected to reduce the frequency of abnormal heart rhythms, such as atrial fibrillation.
Approved indications
- Atrial fibrillation for stroke prevention
Common side effects
- Hypotension
- Bradycardia
- Nausea
Key clinical trials
- SVT-15652 Otic Solution for the Treatment of Otomycosis (PHASE3)
- SVT-15652 Otic Solution for the Treatment of Otomycosis. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |